The Intelligence from The Economist cover image

Square dealing: Jiang Zemin dies

The Intelligence from The Economist

00:00

Breakthroughs in Alzheimer's Treatment

This chapter explores recent clinical trial results for the drug licanumab, indicating a significant reduction in Alzheimer's symptom progression. It reflects on the implications of the amyloid hypothesis, the challenges of drug accessibility, and the complex factors influencing the disease's development.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app